Svmuu News According to a telephone interview on Tuesday, US President Trump stated that the United States will not return to Pakistan for any future peace talks with Iran. Previously, the US delegation concluded marathon negotiations over the weekend but failed to reach an agreement. "Things are happening, but a bit slowly," he said, "We might choose another location; we already have alternatives in mind." When asked if Turkey was being considered, Trump replied, "No, choose a more central location. Perhaps Europe."
After a brief exchange with reporters, Trump called again to add, "You should stay there; something might happen within the next two days. We are more inclined to go to Pakistan. Because that Field Marshal has done an excellent job." He was referring to Pakistani Field Marshal Asim Munir. During the India-Pakistan war last year, Trump established contact with Munir. That war concluded with a peace agreement in just four days through US mediation. "He's great, so we are more likely to go back," Trump said, "Why go to a country that has nothing to do with this?" (Jin10)
Trump's Shifting Stance: Initially Excludes, Then Revises, Still Leaning Towards Pakistan as US-Iran Negotiation Venue
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
7
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
8
MARA Stock Valuation Analysis: Marathon Digital Holdings’ Transition to AI and Long-Term Investment Outlook
-
9
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading










